Asparagine synthetase
Asparagine synthetase | ||
---|---|---|
other names |
Cell cycle control protein TS11 |
|
Properties of human protein | ||
Mass / length primary structure | 54.8 to 64.4 kDa / 478 to 561 amino acids (depending on isoform) | |
Isoforms | 3 | |
Identifier | ||
Gene names | ASNS TS11 | |
External IDs | ||
Enzyme classification | ||
EC, category | 6.3.5.4 , ligase | |
Response type | Amination | |
Substrate | ATP + L -aspartate + L -glutamine + H 2 O | |
Products | AMP + PP i + L -asparagine + L -glutamate | |
Occurrence | ||
Homology family | Asparagine synthetase | |
Parent taxon | Creature | |
Orthologue | ||
human | House mouse | |
Entrez | 440 | 27053 |
Ensemble | ENSG00000070669 | ENSMUSG00000029752 |
UniProt | P08243 | Q61024 |
Refseq (mRNA) | NM_001178075 | NM_012055 |
Refseq (protein) | NP_001171546 | NP_036185 |
Gene locus | Chr 7: 97.85 - 97.87 Mb | Chr 6: 7.68 - 7.69 Mb |
PubMed search | 440 |
27053
|
Asparagine synthetase (ASNS) is an enzyme found in all living things . It catalyzes the body's own production of the amino acid L- asparagine from L- aspartate and L- glutamine .
The enzyme consists of two domains: the part that removes the amino group from glutamine (glutamine amidotransferase, EC 2.4.2.- ); the amino group is channeled as ammonium to the C-terminal end of the enzyme, where aspartate is prepared as β-aspartyl-AMP and finally the amination and separation of AMP takes place.
The catalyzed reaction equilibrium is:
+ L -glutamine + ATP + H 2 O ⇔
⇔ + L -glutamate + AMP + PP i
The reverse reaction can win adenosine triphosphate when asparagine is consumed and becomes active when there is an extreme glucose deficiency, which triggers the increased production of the enzyme. ASNS production is also ramped up in the event of an asparagine deficiency - the transcription factors ATF5 and CHOP play a role here.
Acute lymphoblastic leukemia is combated , among other things, by artificially generated asparagine deficiency with the help of asparaginase . Resistance to this treatment is due to the activity of the ASNS. In order to make this resistance treatable, increasing efforts are being made to find ASNS inhibitors.
Individual evidence
- ↑ UniProt P08243
- ↑ Swiss Institute of Bioinformatics (SIB): PROSITE documentation PDOC00406. Retrieved August 10, 2011 .
- ↑ Cui H, Darmanin S, Natsuisaka M, et al : Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin . In: Cancer Res . 67, No. 7, April 2007, pp. 3345-55. doi : 10.1158 / 0008-5472.CAN-06-2519 . PMID 17409444 .
- ↑ Al Sarraj J, Vinson C, Thiel G: Regulation of asparagine synthetase gene transcription by the basic region leucine zipper transcription factors ATF5 and CHOP . In: Biol. Chem. . 386, No. 9, September 2005, pp. 873-9. doi : 10.1515 / BC.2005.102 . PMID 16164412 .
- ↑ Richards NG, Kilberg MS: asparagine synthetase chemotherapy . In: Annu. Rev. Biochem. . 75, 2006, pp. 629-54. doi : 10.1146 / annurev.biochem.75.103004.142520 . PMID 16756505 .
- ↑ Gutierrez JA, Pan YX, Koroniak L, Hiratake J, Kilberg MS, Richards NG: An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line . In: Chem Biol.. . 13, No. 12, December 2006, pp. 1339-47. doi : 10.1016 / j.chembiol.2006.10.010 . PMID 17185229 .